Nassar Investment Company LLC

FDA Regulatory Profile

Nassar Investment Company LLC appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (H-0860-2026, Class I) was initiated on April 30, 2026.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
H-0860-2026Class IMalazi 100% PURE SUDANESE SESAME Tahina G.W.: 1K.g UPC 6 224011 088244 Produced by: AL-MALAZ COMPANYApril 30, 2026